SLD 0.42 ▲0.00% MBG 0.21 ▲0.00% FDC 3.93 ▼-0.76% LF1 1.87 ▼-2.12% LGF 2.38 ▲0.86% DN1 98.00 ▼-0.17% WMX 1.58 ▼-2.46% RG8 2.52 ▲0.40% CTS 0.89 ▲2.89% TET 0.42 ▲1.20% MRE 1.68 ▲0.00% BST 0.27 ▲3.85% EFR 0.01 ▲0.00% RIV 1.20 ▼-0.42% KIT 1.80 ▲0.56% EMUCA 0.89 RF1 3.38 ▲0.00% AIX 9.00 ▲0.22% SLD 0.42 ▲0.00% MBG 0.21 ▲0.00% FDC 3.93 ▼-0.76% LF1 1.87 ▼-2.12% LGF 2.38 ▲0.86% DN1 98.00 ▼-0.17% WMX 1.58 ▼-2.46% RG8 2.52 ▲0.40% CTS 0.89 ▲2.89% TET 0.42 ▲1.20% MRE 1.68 ▲0.00% BST 0.27 ▲3.85% EFR 0.01 ▲0.00% RIV 1.20 ▼-0.42% KIT 1.80 ▲0.56% EMUCA 0.89 RF1 3.38 ▲0.00% AIX 9.00 ▲0.22%

EPN Epsilon Healthcare Limited

Healthcare · Drug Manufacturers - Specialty & Generic · website
$0.03
52wk 0.02 – 0.04
Overall
55.5
Value
93.2
Growth
79.5
Health
0.4
Quality
31.1
Momentum
71.0
Dividend
—
Price
About Epsilon Healthcare Limited

Epsilon Healthcare Limited, together with its subsidiaries, engages in the healthcare business in Australia. The company operates in three segments, Contract Development and Manufacturing Activities, Telehealth Medical Practice Services, and Pharmacy Services. It is involved in the healthcare and clinics operation; pharmaceutical contract development and manufacturing; development and manufacturing of active pharmaceutical ingredients and finished formulation; and provision of pharmacy services and patient care. The company was formerly known as THC Global Group Limited and changed its name to Epsilon Healthcare Limited in February 2021. Epsilon Healthcare Limited was incorporated in 2016 and is based in Southport, Australia.

Price analytics

Returns

1 day 0.0%
1 week -7.1%
1 month 13.0%
3 months 18.2%
6 months 23.8%
1 year 8.3%
3 years -21.2%

Risk

Volatility (1y ann.) 91.9%
Beta vs ASX 200 -0.20
Sharpe (1y) 0.48
VaR 95% (1-day) -7.4%
Max drawdown (1y) -50.0%
Off 1-year high -31.6%

Technicals

RSI(14) 55
vs 50DMA 4.6%
vs 200DMA 4.4%
Trend Death cross
Fundamental trends
Financial statements
Loading…
Scoring breakdown (2 Oct 2026)
Value 93.2
Trailing P/E
—
Forward P/E
—
PEG ratio
—
EV / EBITDA
100
Price / Book
75
Price / Sales
100
Growth 79.5
Revenue growth (1y)
100
Revenue CAGR (3y)
59
EPS growth (1y)
—
EPS CAGR (3y)
—
Financial Health 0.4
Net debt / EBITDA
—
Interest coverage (EBIT/interest)
0
Current ratio
1
Debt / Equity
0
Quality (Profitability & Cash Flow) 31.1
Return on equity
100
Return on assets
0
Operating margin
0
Net margin
3
Cash conversion (OCF / net income)
—
Dividend / Income —
No meaningful dividend — pillar excluded from the overall score.
Momentum 71.0
6-month return vs ASX 200
100
Price vs 200-day average
65
Price vs 50-day average
73
Position in 52-week range
33

Hover a row's info icon for the exact rule. Bounds and weights are configurable in the Django admin (Scoring configuration).

Score history
Key metrics
Market cap
$10.12M
P/E (trailing)
—
P/E (forward)
—
EPS (trailing)
0.00
Dividend yield
—
Payout ratio
0.0%
Beta
0.75
EV / EBITDA
-21.41
Price / Book
2.60
ROE
50.3%
Operating margin
-15.8%
Net margin
0.5%
Total cash
$1.29M
Total debt
$8.69M
Current ratio
0.82
Debt / Equity
2.24
Free cash flow
$-277,287
Avg volume
180,233
Latest annual results (FY ending 31 Dec 2025)
  • Revenue$9.39M
  • Gross profit$5.76M
  • Operating income-$2.38M
  • Net income-$1.28M
  • Diluted EPS-0.00
  • Free cash flow-$3.30M
  • Net debt$10.11M
Sector peers (Healthcare)
TickerMkt cap P/EScore
CSL $84.15B — 54.3
RMD $45.86B 21.2 74.4
SIG $29.91B 43.3 55.6
FPH $21.64B 57.5 71.1
PME $16.34B 61.8 69.0
RHC $12.56B 40.0 40.2
SHL $9.12B 15.0 43.0
COH $8.20B 55.5 39.4